Publication | Closed Access

Comparative effects of pioglitazone and rosiglitazone on plasma levels of soluble receptor for advanced glycation end products in type 2 diabetes mellitus patients

Metabolic SyndromeBiochemistryMedicineInsulin ManagementDiabetesPhysiologyType 2Diabetes MellitusPharmacologyDiabetes Mellitus PatientsSoluble ReceptorHealth Sciences